EMAIL THIS PAGE TO A FRIEND

Oncotarget

Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma.


PMID 25846753

Abstract

Infection-driven inflammation has been proposed to be involved in the tumorigenesis of head and neck squamous cell carcinoma (HNSCC). Oral HNSCC is often colonized with microbes such as gram-positive bacteria and yeast, where ligands derived from their wall components have been shown to specifically bind to Toll-like receptor 2 (TLR2). Although TLR2 has been described to be expressed in oral HNSCC, its function has not been well characterized. Here, we show the expression of TLR2 in both HNSCC cell lines and primary patient-derived HNSCC xenograft tumors. Activation of TLR2 with a yeast-derived ligand of TLR2, zymosan, promoted organoid formation in an ex vivo model of tumor growth, while blockade with anti-TLR2 antibodies inhibited organoid formation. Zymosan also induced phosphorylation of ERK and the p65 subunit of NF-κB, which was inhibited in the presence of anti-TLR2 antibodies, indicating that this receptor is functional in HNSCC and that the signaling through these pathways is intact. TLR2 blockade also inhibited growth of human xenografted tumors in immunodeficient mice. In summary, our data show that TLR2 is a functional receptor expressed in human HNSCC that plays a direct pro-tumorigenic role, and that it can be therapeutically targeted with blocking antibodies to reduce tumor growth.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

GW22787 Anti-TLR2 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
PRS3135
Anti-TLR2 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
WH0007097M7
Monoclonal Anti-TLR2 antibody produced in mouse, clone 1E7, purified immunoglobulin, buffered aqueous solution
SAB1404474
Monoclonal Anti-TLR2 antibody produced in mouse, clone 2G9, purified immunoglobulin, buffered aqueous solution
SAB1409745
Monoclonal Anti-TLR2 antibody produced in mouse, clone 2A3, purified immunoglobulin, buffered aqueous solution
SAB1409746 Monoclonal Anti-TLR2 antibody produced in mouse, clone 2D2, purified immunoglobulin, buffered aqueous solution
SAB1409747 Monoclonal Anti-TLR2 antibody produced in mouse, clone 3F10, purified immunoglobulin, buffered aqueous solution
SAB1409748 Monoclonal Anti-TLR2 antibody produced in mouse, clone 1E3, purified immunoglobulin, buffered aqueous solution
SAB1409749 Monoclonal Anti-TLR2 antibody produced in mouse, clone 4D6, purified immunoglobulin, buffered aqueous solution
SAB1409750 Monoclonal Anti-TLR2 antibody produced in mouse, clone 4G9, purified immunoglobulin, buffered aqueous solution
SAB1409751 Monoclonal Anti-TLR2 antibody produced in mouse, clone 1C6, purified immunoglobulin, buffered aqueous solution
SAB1409752 Monoclonal Anti-TLR2 antibody produced in mouse, clone 1B10, purified immunoglobulin, buffered aqueous solution
SAB1409753 Monoclonal Anti-TLR2 antibody produced in mouse, clone 4C4, purified immunoglobulin, buffered aqueous solution
SAB1409754 Monoclonal Anti-TLR2 antibody produced in mouse, clone 3H8, purified immunoglobulin, buffered aqueous solution
SAB1409755 Monoclonal Anti-TLR2 antibody produced in mouse, clone 4H6, purified immunoglobulin, buffered aqueous solution